France sets up pricing agreement for surgical meshes:
This article was originally published in Clinica
The French healthcare products economics committee (CEPS) has entered into a pricing agreement with a series of companies regarding tariffs for their surgical meshes. The agreement was published in the Journal officiel of June 17, and has been signed by Bard, Cook France, Cousin Biotech, Pro Concept Chirurgical, Sofradim and Textile Hi-Tec.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.